Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Havrix Immunity Persistence in Adults
NCT03183492Phase 4Withdrawn
- Sponsor
- GSK
- Start
- May 2018
- Primary completion
- Jan 2019
- Modality
- Whole Inactivated Vaccines
01
Overview
A Phase 4 trial of Hepatitis A virus vaccine in hepatitis A (HAV), sponsored by GSK. Planned start May 2018; status: withdrawn.
02
Drugs
Hepatitis A virus vaccine
03
Conditions
hepatitis A (HAV)
Beyond the preview
Go deeper on NCT03183492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03183492.